No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects

M. A. Nauck, H. Holle, M. Kahle, A. Tytko, C. F. Deacon, J. J. Holst, J. J. Meier

Research output: Contribution to journalReviewResearchpeer-review

3 Citations (Scopus)
Original languageEnglish
Article number170176
JournalPeptides
Volume125
ISSN0196-9781
DOIs
Publication statusPublished - 2020

Keywords

  • Gastric inhibitory polypeptide
  • Glucose-dependent insulinotropic peptide
  • Tachyphylaxis
  • Desensitization
  • Insulin secretion
  • Hyperglycaemic clamp

Cite this